Simultaneous In Silico Pharmacokinetic Pharmacodynamic PK PD Modeling of NS3 4AProtease and NS5B Polymerase InhibitorsApplication to Virtual Screening Based Identification of Novel Anti Hepatitis C Virus Agents
